Internal Medicine · Enumclaw, WA
NPI
1770598112
Since 2006
Specialty
Internal Medicine
Code 207R00000X
Group practices
3
Medicare group memberships
Hospitals
3
Hospital affiliations
3021 Griffin Ave
Enumclaw, WA, 98022
Phone (360) 825-6511
Groups this clinician bills Medicare through
Medicare paid, 2024
$241K
4,539 services
Medicare patients, 2024
323
Average age 79
Drug cost, 2024
$1.3M
10,843 prescriptions
Company payments
-
None reported
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jude Gerard D Verzosa was code 99214 (office e&m - established), 680 times for 256 patients. In total Jude Gerard D Verzosa billed 4,539 services in 83 codes, and Medicare paid $241K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-01-18.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 680 | 256 | $95.13 | $65K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 363 | 194 | $13.51 | $4,904 |
| 99497 Care Management/Coordination | Office | 359 | 260 | $79.89 | $29K |
| 17003 Destruction Skin Lesion | Office | 307 | 55 | $6.01 | $1,845 |
| G0446 Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes | Office | 238 | 238 | $27.14 | $6,458 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 233 | 233 | $142.39 | $33K |
| 99215 Office E&M - Established | Office | 232 | 125 | $148.11 | $34K |
| G0444 Annual depression screening, 5 to 15 minutes | Office | 177 | 177 | $21.44 | $3,794 |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 142 | 28 | $0.80 | $113 |
| 83036 Blood Count | Office | 136 | 86 | $9.52 | $1,295 |
| G0008 Administration of influenza virus vaccine | Office | 102 | 98 | $35.39 | $3,610 |
| J1885 Injection, ketorolac tromethamine, per 15 mg | Office | 98 | 30 | $0.54 | $52.51 |
| 90653 Vaccine Product | Office | 89 | 89 | $81.09 | $7,217 |
| 96372 Injection Administration | Office | 85 | 41 | $12.18 | $1,035 |
| 17000 Destruction Skin Lesion | Office | 76 | 60 | $57.36 | $4,360 |
By year: 2022 $274K for 6,800 services; 2023 $282K for 5,363 services; 2024 $241K for 4,539 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 83036 Blood Count | 136 | 86 | $9.52 | $1,295 |
Medicare prescription drug claims, 2024
In 2024, the drug Jude Gerard D Verzosa prescribed most often to Medicare patients was Atorvastatin Calcium, with 897 prescriptions and refills. In total Jude Gerard D Verzosa wrote 10,843 Medicare prescriptions that cost $1.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 897 | 2,439 | 238 | $8,861 |
| Levothyroxine Sodium Generic | 573 | 1,434 | 128 | $5,529 |
| Losartan Potassium Generic | 472 | 1,259 | 118 | $4,445 |
| Lisinopril Generic | 428 | 1,161 | 106 | $3,330 |
| Amlodipine Besylate Generic | 357 | 959 | 96 | $3,062 |
| Rosuvastatin Calcium Generic | 325 | 966 | 99 | $4,776 |
| Alendronate Sodium Generic | 290 | 684 | 79 | $2,816 |
| Metoprolol Succinate Generic | 273 | 642 | 68 | $3,341 |
| Tamsulosin Hcl Generic | 251 | 645 | 63 | $4,348 |
| Omeprazole Generic | 249 | 677 | 68 | $4,005 |
| Ozempic Semaglutide | 245 | 344 | 42 | $325K |
| Pantoprazole Sodium Generic | 243 | 527 | 61 | $3,323 |
| Trazodone Hcl Generic | 216 | 490 | 58 | $2,258 |
| Jardiance Empagliflozin | 212 | 527 | 55 | $306K |
| Gabapentin Generic | 199 | 376 | 51 | $4,044 |
Brand drugs: 1,617 claims; generic drugs: 9,125 claims; opioid claims: 125.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Jude Gerard D Verzosa were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.